Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6APC

Crystal Structure of Infant Antibody ADI-19425

Summary for 6APC
Entry DOI10.2210/pdb6apc/pdb
DescriptorEpididymis luminal protein 214, IGL@ protein, SULFATE ION, ... (4 entities in total)
Functional Keywordsviral fusion glycoprotein, immunoglobulin, respiratory syncytial virus, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight47029.10
Authors
Gilman, M.S.A.,McLellan, J.S. (deposition date: 2017-08-17, release date: 2018-03-21, Last modification date: 2024-10-09)
Primary citationGoodwin, E.,Gilman, M.S.A.,Wrapp, D.,Chen, M.,Ngwuta, J.O.,Moin, S.M.,Bai, P.,Sivasubramanian, A.,Connor, R.I.,Wright, P.F.,Graham, B.S.,McLellan, J.S.,Walker, L.M.
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.
Immunity, 48:339-349.e5, 2018
Cited by
PubMed Abstract: Respiratory syncytial virus (RSV) is a leading cause of infant mortality, and there are currently no licensed vaccines to protect this vulnerable population. A comprehensive understanding of infant antibody responses to natural RSV infection would facilitate vaccine development. Here, we isolated more than 450 RSV fusion glycoprotein (F)-specific antibodies from 7 RSV-infected infants and found that half of the antibodies recognized only two antigenic sites. Antibodies targeting both sites showed convergent sequence features, and structural studies revealed the molecular basis for their recognition of RSV F. A subset of antibodies targeting one of these sites displayed potent neutralizing activity despite lacking somatic mutations, and similar antibodies were detected in RSV-naive B cell repertoires, suggesting that expansion of these B cells in infants may be possible with suitably designed vaccine antigens. Collectively, our results provide fundamental insights into infant antibody responses and a framework for the rational design of age-specific RSV vaccines.
PubMed: 29396163
DOI: 10.1016/j.immuni.2018.01.005
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.7 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon